0001181431-12-036820.txt : 20120615
0001181431-12-036820.hdr.sgml : 20120615
20120615170136
ACCESSION NUMBER: 0001181431-12-036820
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120606
FILED AS OF DATE: 20120615
DATE AS OF CHANGE: 20120615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROE WAYNE I
CENTRAL INDEX KEY: 0001216990
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35396
FILM NUMBER: 12910700
MAIL ADDRESS:
STREET 1: 5311 ELSMERE AVENUE
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ISTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000930553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330511719
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-788-6000
MAIL ADDRESS:
STREET 1: 50 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED CORNEAL SYSTEMS INC
DATE OF NAME CHANGE: 20000403
4
1
rrd348841.xml
FORM 4
X0305
4
2012-06-06
1
0000930553
ISTA PHARMACEUTICALS INC
ISTA
0001216990
ROE WAYNE I
50 TECHNOLOGY DRIVE
IRVINE
CA
92618
1
0
0
0
Common Stock
2012-06-06
4
D
0
38558
9.10
D
0
D
Option (right to buy)
3.89
2012-06-06
4
D
0
20000
D
2021-12-05
Common Stock
20000
0
D
Option (right to buy)
4.58
2012-06-06
4
D
0
20000
D
2020-12-06
Common Stock
20000
0
D
Option (right to buy)
4.72
2012-06-06
4
D
0
20000
D
2019-12-07
Common Stock
20000
0
D
Option (right to buy)
0.79
2012-06-06
4
D
0
11100
D
2018-12-10
Common Stock
11100
0
D
Option (right to buy)
6.90
2012-06-06
4
D
0
11100
D
2017-10-11
Common Stock
11100
0
D
Option (right to buy)
6.08
2012-06-06
4
D
0
16000
D
2016-10-19
Common Stock
16000
0
D
Option (right to buy)
5.82
2012-06-06
4
D
0
16000
D
2015-10-13
Common Stock
16000
0
D
Option (right to buy)
10.75
2012-06-06
4
D
0
9000
D
2014-10-20
Common Stock
9000
0
D
Option (right to buy)
6.96
2012-06-06
4
D
0
16250
D
2013-09-10
Common Stock
16250
0
D
Disposed of pursuant to agreement and plan of merger by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.21 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
The option which was fully vested on 12/06/11 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.52 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
The option which was fully vested on 12/07/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.38 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
The option which was fully vested on 12/10/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.31 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
The option which was fully vested on 10/11/08 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.20 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
The option which was fully vested on 10/19/07 was cancelled in the Merger Agreement in exchange for a cash payment equal to $3.02 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
The option which was fully vested on 10/13/06 was cancelled in the Merger Agreement in exchange for a cash payment equal to $3.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
The option which was fully vested on 10/20/05 was cancelled in the Merger Agreement.
The option which was fully vested on 09/10/04 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.14 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
/s/ Brian Drazba, Attorney-in-Fact for Wayne I. Roe
2012-06-15